CYNTHIA MARSH: Open Payments
NPI 1407363989 · JOHNSON CITY, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,419 in 62 payments from 16 companies in 2025. Trend: 2023 $794 · 2024 $1,319 · 2025 $1,419
Food & beverage: $1,419
| Company | Payments | Amount |
|---|---|---|
| AKEBIA THERAPEUTICS INC | 8 | $368 |
| Travere Therapeutics, Inc. | 16 | $329 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $170 |
| AstraZeneca Pharmaceuticals LP | 8 | $162 |
| Novartis Pharmaceuticals Corporation | 4 | $81 |
| Otsuka America Pharmaceutical, Inc. | 3 | $51 |
| Fresenius USA Marketing, Inc. | 2 | $38 |
| Calliditas Therapeutics US Inc. | 1 | $35 |
| Amgen Inc. | 2 | $35 |
| Daiichi Sankyo Inc. | 1 | $28 |
Products named: Vafseo, Kerendia, FARXIGA, Fabhalta, JYNARQUE, VELPHORO, TARPEYO, INJECTAFER.
Industry payments across TN — which companies pay providers there.
